Medications for Hyperaldosteronism

22 results

  • Spironolactone (spironolactone)

    (Spironolactone)
    QPharma Inc
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It helps improve survival, manage fluid retention, lower blood pressure, and maintain potassium levels in patients unable to respond adequately to other treatments.

  • Spironolactone (spironolactone)

    (spironolactone)
    REMEDYREPACK INC.
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension (as add-on therapy), edema from liver cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and maintenance therapy). It enhances survival, manages edema, and reduces hospitalization needs, along with lowering blood pressure.

  • Spironolactone (spironolactone)

    (Spironolactone)
    Asclemed USA, Inc.
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension as add-on therapy, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It helps improve survival, manage edema, reduce hospitalizations, and lower blood pressure.

  • Spironolactone (spironolactone)

    (spironolactone)
    REMEDYREPACK INC.
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It enhances survival in heart failure, lowers blood pressure, manages edema, and serves as preoperative or long-term therapy in hyperaldosteronism cases.

  • Spironolactone (spironolactone)

    (SPIRONOLACTONE)
    Bryant Ranch Prepack
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension (as add-on therapy), edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and long-term maintenance). It enhances survival, manages edema, and reduces hospitalization needs in heart failure.

  • Spironolactone (spironolactone)

    (SPIRONOLACTONE)
    Sun Pharmaceutical Industries, Inc.
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension, edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and maintenance therapy). It enhances survival, lowers blood pressure, manages edema, and addresses hyperaldosteronism in specific patient populations.

  • Spironolactone (spironolactone)

    (Spironolactone)
    American Health Packaging
    Usage: Spironolactone is indicated for treating NYHA Class III-IV heart failure, hypertension as add-on therapy, edema due to hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It enhances survival, manages edema, reduces hospitalization for heart failure, and addresses uncontrolled hypertension effectively.

  • Spironolactone (spironolactone)

    (SPIRONOLACTONE)
    Bryant Ranch Prepack
    Usage: Spironolactone tablets are indicated for treating NYHA Class III-IV heart failure, hypertension as add-on therapy, edema associated with hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism. It enhances survival, manages edema, lowers blood pressure, and is used in specific conditions resistant to other treatments.

  • Spironolactone (spironolactone)

    (SPIRONOLACTONE)
    Bryant Ranch Prepack
    Usage: Spironolactone is indicated for treating heart failure (NYHA Class III-IV), hypertension (as adjunct therapy), edema due to hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism (both preoperative and long-term management). It helps improve survival, manage edema, and lower blood pressure while reducing hospitalization needs.

  • Spironolactone (spironolactone)

    (spironolactone)
    REMEDYREPACK INC.
    Usage: Spironolactone is indicated for treating NYHA Class III–IV heart failure, hypertension as add-on therapy, managing edema from hepatic cirrhosis or nephrotic syndrome, and primary hyperaldosteronism preoperatively and for long-term maintenance in specific patients. It is often used with other therapies for optimal outcomes.